[Whole-body tumor staging: MRI or FDG-PET/CT?]
- PMID: 15349729
- DOI: 10.1007/s00117-004-1093-x
[Whole-body tumor staging: MRI or FDG-PET/CT?]
Abstract
Technical innovations such as the availability of movable patient platforms and the introduction of 32-channel systems have made whole-body MRI for tumor staging feasible. In addition, the development of dual-modality PET/CT systems offers the opportunity to perform anatometabolic tumor staging with whole-body coverage in a single session. Based on an increase in patient survival when applying a stage-adapted therapy in different malignant diseases the relevant question relates to the accuracies of whole-body MRI and whole-body PET/CT for TNM staging. This review article addresses whole-body tumor staging with MRI and FDG-PET/CT with special emphasis on diagnostic accuracies for staging different malignant diseases.
Similar articles
-
Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology.JAMA. 2003 Dec 24;290(24):3199-206. doi: 10.1001/jama.290.24.3199. JAMA. 2003. PMID: 14693872
-
[Comparison of high resolution whole-body MRI using parallel imaging and PET-CT. First experiences with a 32-channel MRI system].Radiologe. 2004 Sep;44(9):889-98. doi: 10.1007/s00117-004-1102-0. Radiologe. 2004. PMID: 15349732 German.
-
Ionising radiation-free whole-body MRI versus (18)F-fluorodeoxyglucose PET/CT scans for children and young adults with cancer: a prospective, non-randomised, single-centre study.Lancet Oncol. 2014 Mar;15(3):275-85. doi: 10.1016/S1470-2045(14)70021-X. Epub 2014 Feb 19. Lancet Oncol. 2014. PMID: 24559803
-
Whole-body MRI and FDG PET fused images for evaluation of patients with cancer.AJR Am J Roentgenol. 2009 Apr;192(4):1012-20. doi: 10.2214/AJR.08.1498. AJR Am J Roentgenol. 2009. PMID: 19304708 Review.
-
Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.Top Magn Reson Imaging. 2007 Jun;18(3):193-202. doi: 10.1097/RMR.0b013e318093e6bo. Top Magn Reson Imaging. 2007. PMID: 17762383 Review.
Cited by
-
Gastrointestinal 18F-FDG accumulation on PET without a corresponding CT abnormality is not an early indicator of cancer development.Eur Radiol. 2009 Sep;19(9):2171-9. doi: 10.1007/s00330-009-1405-7. Epub 2009 May 5. Eur Radiol. 2009. PMID: 19415294
-
[Whole-body staging of malignant melanoma: advantages, limitations and current importance of PET-CT, whole-body MRI and PET-MRI].Radiologe. 2015 Feb;55(2):120-6. doi: 10.1007/s00117-014-2762-z. Radiologe. 2015. PMID: 25589421 German.
-
MRI of respiratory dynamics with 2D steady-state free-precession and 2D gradient echo sequences at 1.5 and 3 Tesla: an observer preference study.Eur Radiol. 2009 Feb;19(2):391-9. doi: 10.1007/s00330-008-1148-x. Epub 2008 Sep 6. Eur Radiol. 2009. PMID: 18777025
-
[Cost considerations for whole-body MRI and PET/CT as part of oncologic staging].Radiologe. 2008 Apr;48(4):384-96. doi: 10.1007/s00117-007-1547-z. Radiologe. 2008. PMID: 17891370 German.
-
Incidental head and neck (18)F-FDG uptake on PET/CT without corresponding morphological lesion: early predictor of cancer development?Eur J Nucl Med Mol Imaging. 2009 Sep;36(9):1397-406. doi: 10.1007/s00259-009-1113-1. Epub 2009 Mar 21. Eur J Nucl Med Mol Imaging. 2009. PMID: 19305995
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical